The Valley Desk

NCT07540988 · Interventional trial

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Overall registry status Recruiting

Phase 3

Conditions Interstitial Lung Diseases

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov